GlycoMimetics Inc (GLYC) Stock
GLYC is no longer traded. GlycoMimetics was delisted from the Nasdaq in June 2025.
Prices on this page are historical; the last trade was June 13, 2025 at $0.16.
GlycoMimetics stock price history
GLYC final trading statistics
- Final close
- $0.16
- Final trading day
- Jun 13, 2025
- Market cap at delisting
- $10.13M
- Shares outstanding
- 64.53M
- Final 52-week range
- $0.14 – $18.40
- Avg. volume (final 3 mo.)
- 1,726,386
- All-time high (split-adj.)
- $25.35 · Feb 2018
- All-time low (split-adj.)
- $0.14 · Oct 2024
- Return since IPO
- -98.3%
- Beta
- 1.60
- Book value / share
- $5.23
- Price / book
- 0.03
GlycoMimetics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$37.9M | -$0.59 |
| FY2023 | $10.0K | -$36.9M | -$0.58 |
| FY2022 | $74.9K | -$93.3M | -$0.88 |
| FY2021 | $1.16M | -$63.1M | -$1.23 |
| FY2020 | $10.16M | -$50.3M | -$1.11 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About GlycoMimetics Inc
GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.
GlycoMimetics stock FAQ
What happened to GlycoMimetics stock?
GlycoMimetics stock was delisted from the Nasdaq. Its final close was $0.16 on June 13, 2025.
Is GLYC stock still trading?
No. GLYC was delisted from the Nasdaq in June 2025 and no longer trades on a U.S. exchange.
What was the last price of GLYC stock?
GLYC closed at $0.16 on its final trading day, June 13, 2025, for a market value of about $10.13M.
What were GlycoMimetics's revenue and earnings in its last full fiscal year?
GlycoMimetics reported revenue of $0.00 and net income of -$37.9M in fiscal 2024, its last full year as a public company.
When did GlycoMimetics go public?
GlycoMimetics Inc stock began trading on January 10, 2014.